CasLoc logo
All Cases PTAB Litigations UPC Oppositions

Endo Pharmaceuticals Inc. v. Amneal Pharmaceuticals LLC

1:14-cv-01382

Overview

Case Number 1:14-cv-01382
Filing Date 2014-11-07
Status Terminated
Termination Date 2019-05-20
Court District Court, D. Delaware (ded)
Nature of Suit 830 Patent
Jurisdiction Type Federal Question
Cause of Action 35:271 Patent Infringement
Jury Demand None

Parties

Defendant

Mallinckrodt LLC Operating Company

Represented By

4 Attorneys Listed

Stephen J. Kraftschik

Polsinelli PC

Tel: +1 (302) 252-0926
Fax: +1 (302) 252-0921

222 Delaware Avenue, Suite 1101, Wilmington, DE 19801

Derek James Fahnestock

Morris, Nichols, Arsht & Tunnell LLP

Tel: +1 (302) 658-9200

1201 North Market Street, P.O. Box 1347

Julia Heaney

Morris, Nichols, Arsht & Tunnell LLP

Tel: +1 (302) 658-9200

1201 North Market Street, P.O. Box 1347

Jack B. Blumenfeld

Morris, Nichols, Arsht & Tunnell LLP

Tel: +1 (302) 658-9200

1201 North Market Street, P.O. Box 1347

Endo Pharmaceuticals Inc. Operating Company

Represented By

8 Attorneys Listed

Stephen J. Kraftschik

Polsinelli PC

Tel: +1 (302) 252-0926
Fax: +1 (302) 252-0921

222 Delaware Avenue, Suite 1101, Wilmington, DE 19801

Sharon K. Gagliardi

Email: sharon.gagliardi@dechert.com

Julie Latsko

UNDELIVERABLE EMAIL 4/13/2017

Joseph J. Gribbin

Email: joseph.gribbin@dechert.com

Derek James Fahnestock

Morris, Nichols, Arsht & Tunnell LLP

Tel: +1 (302) 658-9200

1201 North Market Street, P.O. Box 1347

Blake B. Greene

Email: blake.greene@dechert.com

Julia Heaney

Morris, Nichols, Arsht & Tunnell LLP

Tel: +1 (302) 658-9200

1201 North Market Street, P.O. Box 1347

Jack B. Blumenfeld

Morris, Nichols, Arsht & Tunnell LLP

Tel: +1 (302) 658-9200

1201 North Market Street, P.O. Box 1347

Counter Claimant

Amneal Pharmaceuticals LLC Operating Company

Represented By

10 Attorneys Listed

Uma N. Everett

Email: ueverett@sternekessler.com

Rami Bardenstein

UNDELIVERABLE 12/28/2016

UNDELIVERABLE 12/28/2016

Paul A. Ainsworth

Email: painsworth@skgf.com

Oren D. Langer

Email: olanger@robinskaplan.com

Krishan Y. Thakker

Email: kthakker@skgf.com

Kelsey J. McElveen

UNDELIVERABLE EMAIL 6/7/2022

Jamie R. Kurtz

Email: jkurtz@robinskaplan.com

Jake M. Holdreith

Email: jholdreith@robinskaplan.com

Andrew M. Nason

Email: anason@skgf.com

Mary Matterer

ADDRESS EXPIRED / UNKNOWN

Tel: +1 (302) 888-6800
Fax: +1 (302) 571-1750

ADDRESS EXPIRED / UNKNOWN, (302) 888-6800

Amneal Pharmaceuticals of New York LLC Operating Company

Represented By

1 Attorneys Listed

Mary Matterer

ADDRESS EXPIRED / UNKNOWN

Tel: +1 (302) 888-6800
Fax: +1 (302) 571-1750

ADDRESS EXPIRED / UNKNOWN, (302) 888-6800

Court & Judges

Court

District Court, D. Delaware (ded)

Global Patent Family Cross-Litigation Radar

CasLoc 360° Radar 5 Family Members

Multi-jurisdiction dispute tracking across USPTO PTAB, U.S. Federal Courts, Unified Patent Court (UPC), and EPO Oppositions

🇺🇸
U.S. District Courts Counterparts in force
🏛️
USPTO PTAB Trials Counterparts in force
🇪🇺
Unified Patent Court (UPC) Counterparts in force
🇩🇪
European Patent Office (EPO) Counterparts in force
Worldwide Family Members (5): 🇺🇸 US
Parallel Proceedings Across Jurisdictions (0 found):

No active co-pending lawsuits found across other jurisdictions for this family. All related sibling filings are currently unlitigated.

Stay ahead of cross-border rulings. Subscribe for free automated docket alerts across U.S. Courts, PTAB, UPC, and EPO.

Patents Involved

2 Patents

There are 2 patents involved in this case.

Patent Asset Filing & Issue Date Expiration & Term Status External Links
US8808737
Method of treating pain utilizing controlled release oxymorphone pharmaceutical compositions and instruction on dosing for renal impairment
Filed: 2010-03-03
Issued: 2014-08-19
Active (3.3 yrs remaining)
Expires: 2030-03-03
US8871779
Process for preparing morphinan-6-one products with low levels of α,β-unsaturated ketone compounds
Filed: 2007-03-02
Issued: 2014-10-28
Active (3.0 yrs remaining) +996d PTA
Expires: 2029-11-22

Patent Enforceability & Injunction Risk Assessment

Statutory Analysis
Injunction Viability (35 U.S.C. § 283) Active Threat

Active Threat — Patent is within enforceable statutory term; injunctive relief viable.

Terminal Disclaimer & Cellect Risk Low Risk

Standard Statutory Term — No obviousness-type double patenting noted.

Damages Lookback Horizon 6-Yr Max Lookback

Under 35 U.S.C. § 286, damages cannot accrue for infringement prior to 6 years before filing. All Statutory Maintenance Fees Paid (12-Year Window Cleared).

Procedural Motions & Interlocutory Orders

Motion Intelligence

Total Motions

6

Dispositive

4

Granted

0

Denied

0

Pending / Review

6

Motions by Category

Procedural / Extension Motion 2 Motion to Transfer Venue (28 U.S.C. § 1404) 4

Key Dispositive Motions & Rulings

Motion to Transfer Venue (28 U.S.C. § 1404) Pending / Under Review
STIPULATION TO EXTEND TIME for Plaintiffs to Respond to Motion to Transfer and Defendants to File Reply Brief to March 10, 2015 and April 28, 2015, respectively...
Entry #20 • 2015-02-27 Document →
Motion to Transfer Venue (28 U.S.C. § 1404) Pending / Under Review
STIPULATION TO EXTEND TIME to answer counterclaims; to respond to Motion to Transfer; to file a reply brief to March 6, 2015 (Answer Counterclaims); March 2, 20...
Entry #19 • 2015-02-04 Document →
Motion to Transfer Venue (28 U.S.C. § 1404) Pending / Under Review
MOTION to Transfer and Consolidate - filed by Amneal Pharmaceuticals LLC, Amneal Pharmaceuticals of New York LLC. (Matterer, Mary) Modified on 1/22/2015 (nms). ...
Entry #14 • 2015-01-21 Document →
Motion to Transfer Venue (28 U.S.C. § 1404) Pending / Under Review
[SEALED] OPENING BRIEF in Support re 14 MOTION to Transfer and Consolidate, filed by Amneal Pharmaceuticals LLC, Amneal Pharmaceuticals of New York LLC.Answerin...
Entry #15 • 2015-01-21 Document →
Procedural / Extension Motion Pending / Under Review
STIPULATION TO EXTEND TIME for Defendants to answer, move, or otherwise respond to the Complaint to January 20, 2015 - filed by Amneal Pharmaceuticals LLC, Amne...
Entry #11 • 2015-01-09 Document →
Procedural / Extension Motion Pending / Under Review
STIPULATION TO EXTEND TIME for Defendants to answer, move or otherwise respond to the Complaint to January 16, 2015 - filed by Amneal Pharmaceuticals LLC, Amnea...
Entry #8 • 2014-11-25 Document →

Docket Entries

(23 total)
Pleading / Complaint

COMPLAINT - filed against Amneal Pharmaceuticals LLC, Amneal Pharmaceuticals of New York LLC - Magistrate Consent Notice to Pltf. ( Filing fee $ 400, receipt number 0311-1622579.) - filed by Mallinckrodt LLC, Endo Phamaceuticals Inc.. (Attachments: # 1 Exhibit A-B, # 2 Civil Cover Sheet)(rwc) (Entered: 11/10/2014)

Entry #1 • 2014-11-07
1

Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (rwc) (Entered: 11/10/2014)

Entry #2 • 2014-11-07
1

Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 8,808,737 B2; 8,871,779 B2. (rwc) (Entered: 11/10/2014)

Entry #3 • 2014-11-07
1

Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Endo International PLC for Endo Phamaceuticals Inc. filed by Endo Phamaceuticals Inc.. (rwc) (Entered: 11/10/2014)

Entry #4 • 2014-11-07
1

Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Mallinckrodt plc, Other Affiliate Mallinckrodt Inc. for Mallinckrodt LLC filed by Mallinckrodt LLC. (rwc) Modified on 11/10/2014 (rwc). (Entered: 11/10/2014)

Entry #5 • 2014-11-07
1

Track Case Updates

Automated email notifications for new filings & decisions

Identifier: •

Free service • 1-click unsubscribe anytime • Powered by CasLoc